Idaho Senate brings back Medicaid expansion bill | Idaho Statesman
Rejecting action by the House a day earlier, the Idaho Senate has resurrected a shelved House proposal to begin immediate negotiations on federal approval for a modified approach to provide subsidized health care for 78,000 insured Idahoans.
Critics in Connecticut urge more transparency in Anthem-Cigna merger review | (Hartford, Conn.) CT Mirror
Saying that “all eyes will be on Connecticut,” critics of two pending mergers of major health insurers have asked the state’s insurance commissioner to take steps they say would increase transparency in the review of Anthem’s proposed acquisition of Cigna.
Baton Rouge General, Ochsner plan partnership |(Baton Rouge, La.) Advocate
A partnership is being formed by Baton Rouge (La.) General’s parent company and Ochsner Health System to jointly operate their three local hospitals and 31 clinics.
Scathing report finds Michigan 'fundamentally accountable' for Flint's water crisis | Los Angeles Times
After months of finger-pointing over who is responsible for the water contamination problem in Flint, Mich., a scathing report squarely names the very people who vowed to root out who was to blame — the state itself.
Wanted: more black and Latino doctors | Marketplace.org
Together, African-Americans, Latinos and Native Americans make up about a quarter of the U.S. population, but just 9% of doctors. Meanwhile, the number of black men applying to medical school is lower than it was in the late 1970s. Health experts say the lack of diversity in medicine contributes to disparities in the care patients receive.
Columbia Care serves as the connection between doctors, medical marijuana patients | Rochester (N.Y.) Democrat and Chronicle
People having a hard time finding a doctor to approve them for medical marijuana may get more help from a company making and selling the medication than from the New York Department of Health, which runs the program.
Bristol-Myers Squibb pays $600M for biotech startup | Boston Business Journal
Bristol-Myers Squibb shelled out $225 million now and marked another $375 million in potential future payments to acquire Padlock Therapeutics, a 15-month-old startup owned by Atlas Venture. Padlock is a 10-person company researching ways to fight autoimmune disease.
Inspira reaches revised hospital deal with Rowan University | CBS Philly
A new deal has been approved by Rowan University to sell some 100 acres of land, just outside Glassboro, N.J., to the Inspira Health Network. The site is targeted for use as a new hospital.